Download facts about maple syrup urine disease (msud)

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Gene wikipedia , lookup

Genetic engineering wikipedia , lookup

Molecular ecology wikipedia , lookup

Amino acid synthesis wikipedia , lookup

Genetic code wikipedia , lookup

Personalized medicine wikipedia , lookup

Point mutation wikipedia , lookup

Transcript
Genetics Uncoded:
FACTS ABOUT MAPLE SYRUP URINE DISEASE (MSUD)
AKA | BCKD deficiency, Branched-chain alpha-keto acid dehydrogenase deficiency, Branched-chain ketoaciduria, Ketoacidemia, MSUD
What Your Test Results Mean
Test results indicate that you are a carrier of maple syrup urine disease (MSUD). Carriers typically show no symptoms of MSUD; however, carriers are at an increased risk of having a child with MSUD. Risk for the current or
future pregnancies is dependent on your partner’s carrier status. Carrier testing of your partner is recommended
in addition to consultation with a genetic counselor for more detailed risk assessment.
MSUD Explained
How the Genetics Work
MSUD is an inherited metabolic disorder named for the
characteristic maple syrup smell in the urine of individuals
with MSUD. The disease is characterized by irritability, poor
feeding, lethargy, seizures, and coma in infancy if untreated.
Adolescents and adults with MSUD are at increased risk for
ADHD, depression, and anxiety disorders.
The clinical features of MSUD can be explained by mutations
in one of three genes, BCKDHA, BCKDHB, or DBT. At least
80% of MSUD is caused by mutations in BCKDHA or BCKDHB.
The remaining 20% of MSUD is caused by mutations in the
DBT gene. Individuals have two copies of each of the genes
causing MSUD. Carriers of MSUD have a single mutation in
one of the MSUD genes while individuals with MSUD have
mutations in both copies of one of the MSUD genes, one
inherited from each parent.
Individuals with MSUD do not produce enough of one of the
enzymes, branched-chain alpha-ketoacid dehydrogenase,
needed to metabolize branched-chain amino acids. The
build-up of branched-chain amino in tissues and plasma
cause signs of the disease. With appropriate medical
management, normal growth and development are possible.
Treatment of individuals with MSUD consists of dietary leucine
restriction, branched chain amino acid-free medical foods,
in addition to supplementation with isoleucine and valine,
and frequent clinical and biochemical monitoring. For classic
MSUD, liver transplant is also an effective therapy. Transplant
eliminates dietary restrictions and provides protection from
decompensations during illness.
Recommended Next Steps
Carrier testing of your partner is recommended in addition to
consultation with a genetic counselor for more detailed risk
assessment.
Questions?
Contact us at 1-855-776-9436 to set up an appointment to
discuss your results in more detail with a NxGen MDx genetic
counselor.
Precise genetic carrier screening
801 Broadway Ave NW, Suite 203, Grand Rapids, MI 49504 • Phone: (855) 776-9436 • Fax: (616) 710-4667
[email protected] • www.nxgenmdx.com
© 2015 NxGen MDx